Bhagiradha Chemicals & Industries Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
BHAGCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bhagiradha Chemicals has filed a statement of deviation or variation under Regulation 32 of SEBI's Listing Obligations and Disclosure Requirements (LODR) with the NSE. This regulation requires companies to report any change in the use of funds raised through a public issue, rights issue, preferential allotment, or qualified institutional placement, compared to the purpose originally disclosed in the offer document. The exact nature, amount, and reasons for the deviation are not visible in the headline and would be in the attached document. Investors should review the detailed filing on the NSE portal to understand whether the funds have been used differently than originally planned and whether management has provided a satisfactory explanation.
This is a routine compliance disclosure, but the underlying deviation could matter to shareholders if the company has used raised funds for purposes not originally approved. A minor or explained deviation is generally neutral; a large unexplained one may raise governance concerns and could weigh on investor sentiment.